4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H,6H,7H-pyrazolo[3,4-d]pyridazin-7-one
Structure Info
- Chemspace ID
- CSSB03437847725 (In-Stock Building Blocks)
- MFCD
- MFCD34167515, MFCD32710277
- IUPAC Name
- 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H,6H,7H-pyrazolo[3,4-d]pyridazin-7-one
- Mol formula
- C25H24N6O3
- Mol weight
- 457 Da
- Catalog Number(s)
- AA01V795, AG01V7BX, AKOS040759942, AR01V80X, BD01487050, BF35253, BUP07747, EC01V9HP, G17761, HY-131705, M28846, MS-28324, ST01V8SP, T9706, TX01V8HL, Y1091552
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.53
- Heavy atoms count
- 34
- Rotatable bond count
- 5
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.2
- Polar surface area (Å)
- 115
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 2
![Chemical structure of 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H,6H,7H-pyrazolo[3,4-d]pyridazin-7-one (C25H24N6O3) - CSSB03437847725](/st/structure/200/f82f045353ec6bbd0ada4d041d836c97/NC1%253DNNC%2528%253DO%2529C2%253DC1C%2528%253DNN2%255BC%2540%2540H%255D1CCCN%2528C1%2529C%2528%253DO%2529C%253DC%2529C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1.png "C25H24N6O3")
- Zoom the structure
- CSSB03437847725
Items Overall 40 items from 6 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 7 days | United States To: | 90 | 1 mg | 149.60 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 5 mg | 256.30 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 10 mg | 371.80 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 25 mg | 567.60 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 50 mg | 735.90 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 100 mg | 1,008.70 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 200 mg | 1,312.30 | |
Description: BTK inhibitor 17; CAS: 1858206-76-4 | ||||||
| Angene International Limited | 10 days | China To: | 90 | 1 mg | 90.00 | |
| Angene International Limited | 10 days | China To: | 90 | 5 mg | 230.40 | |
| Angene International Limited | 10 days | China To: | 90 | 10 mg | 346.50 | |
| Angene International Limited | 10 days | China To: | 90 | 25 mg | 532.80 | |
| Angene International Limited | 10 days | China To: | 90 | 50 mg | 719.10 | |
| Angene International Limited | 10 days | China To: | 90 | 100 mg | 969.30 | |
| Angene International Limited | 10 days | China To: | 90 | 200 mg | 1,276.20 | |
Description: BTK inhibitor 17; CAS: 1858206-76-4 | ||||||
| A2B Chem | 12 days | United States To: | 99 | 1 mg | 85.10 | |
| A2B Chem | 12 days | United States To: | 99 | 5 mg | 175.95 | |
| A2B Chem | 12 days | United States To: | 99 | 10 mg | 273.70 | |
| A2B Chem | 12 days | United States To: | 99 | 25 mg | 440.45 | |
| A2B Chem | 12 days | United States To: | 99 | 50 mg | 583.05 | |
| A2B Chem | 12 days | United States To: | 99 | 100 mg | 815.35 | |
Description: BTK inhibitor 17; CAS: 1858206-76-4 | ||||||
| AA BLOCKS | 12 days | United States To: | 90 | 1 mg | 108.90 | |
| AA BLOCKS | 12 days | United States To: | 90 | 5 mg | 199.10 | |
| AA BLOCKS | 12 days | United States To: | 90 | 10 mg | 297.00 | |
| AA BLOCKS | 12 days | United States To: | 90 | 25 mg | 462.00 | |
| AA BLOCKS | 12 days | United States To: | 90 | 50 mg | 603.90 | |
| AA BLOCKS | 12 days | United States To: | 90 | 100 mg | 834.90 | |
Description: BTK inhibitor 17; CAS: 1858206-76-4 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 90 | 1 mg | 150.70 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 5 mg | 387.20 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 10 mg | 581.90 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 25 mg | 894.30 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 50 mg | 1,205.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 100 mg | 1,626.90 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 200 mg | 2,140.60 | |
Description: BTK inhibitor 17; CAS: 1858206-76-4 | ||||||
| 10X CHEM | TBD | United States To: | 90 | 1 mg | 68.20 | |
| 10X CHEM | TBD | United States To: | 90 | 5 mg | 139.70 | |
| 10X CHEM | TBD | United States To: | 90 | 10 mg | 218.90 | |
| 10X CHEM | TBD | United States To: | 90 | 25 mg | 350.90 | |
| 10X CHEM | TBD | United States To: | 90 | 50 mg | 464.20 | |
| 10X CHEM | TBD | United States To: | 90 | 100 mg | 649.00 | |
| 10X CHEM | TBD | United States To: | 90 | 200 mg | 854.70 | |
Description: BTK inhibitor 17; CAS: 1858206-76-4 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 5-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H-pyrazole-4-carboxamide - CSSB00138413531](/st/structure/200/5bb038f7a8a1fbee861899ccbab8ce40/NC%2528%253DO%2529C1%253DC%2528N%2529N%2528N%253DC1C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1%2529%255BC%2540%2540H%255D1CCCN%2528C1%2529C%2528%253DO%2529C%253DC.png)
![Chemical structure of 3-(4-phenoxyphenyl)-5-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-4,5,7,9,13-pentaazatricyclo[7.4.0.0²,⁶]trideca-1(13),2(6),3,7-tetraen-12-one - CSSB00102518468](/st/structure/200/87d149772faa2ed6626553b0bc97174b/C%253DCC%2528%253DO%2529N1CCC%255BC%2540H%255D%2528C1%2529N1N%253DC%2528C2%253DC1N%253DCN1CCC%2528%253DO%2529N%253DC21%2529C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1.png)
![Chemical structure of 4-amino-3-(4-phenoxycyclohexa-1,3-dien-1-yl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H,6H,7H-pyrazolo[3,4-d]pyridazin-7-one - CSSB14945382360](/st/structure/200/4e4c3335fcec8b0fcf2e396306f80bc6/Nc1n%255BnH%255Dc%2528%253DO%2529c2n%2528nc%2528C3%253DCC%253DC%2528CC3%2529Oc3ccccc3%2529c12%2529%255BC%2540%2540H%255D1CCCN%2528C1%2529C%2528%253DO%2529C%253DC.png)
![Chemical structure of 4-amino-3-[4-(2,6-difluorophenoxy)phenyl]-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H,6H,7H-pyrrolo[2,3-d]pyridazin-7-one - CSSB06741707247](/st/structure/200/f088d956039f3f9315700e2da4fddb82/Nc1n%255BnH%255Dc%2528%253DO%2529c2n%2528cc%2528-c3ccc%2528Oc4c%2528F%2529cccc4F%2529cc3%2529c12%2529%255BC%2540%2540H%255D1CCCN%2528C1%2529C%2528%253DO%2529C%253DC.png)
![Chemical structure of 4-amino-3-(4-phenoxyphenyl)-1-(propan-2-yl)-1H,6H,7H-pyrazolo[3,4-d]pyridazin-7-one - CSSB06741707252](/st/structure/200/f750b4cfd3f50685b0b0dd329a2cb2eb/CC%2528C%2529n1nc%2528-c2ccc%2528Oc3ccccc3%2529cc2%2529c2c%2528N%2529n%255BnH%255Dc%2528%253DO%2529c12.png)
![Chemical structure of 1-{3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one - CSSB00020668645](/st/structure/200/cdd61d0095b1468e6d47e3a923284189/NC1%253DC2C%2528%253DNC%253DN1%2529N%2528N%253DC2C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1%2529C1CCCN%2528C1%2529C%2528%253DO%2529C%253DC.png)
![Chemical structure of 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one - CSSB00015189027](/st/structure/200/ff93019def0b92af2d93e9799511c169/NC1%253DC2C%2528%253DNC%253DN1%2529N%2528N%253DC2C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1%2529%255BC%2540%2540H%255D1CCCN%2528C1%2529C%2528%253DO%2529C%253DC.png)
